These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2589307)

  • 1. Noncontraceptive estrogen use and epithelial ovarian cancer.
    Kaufman DW; Kelly JP; Welch WR; Rosenberg L; Stolley PD; Warshauer ME; Lewis J; Woodruff J; Shapiro S
    Am J Epidemiol; 1989 Dec; 130(6):1142-51. PubMed ID: 2589307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncontraceptive estrogen use and the occurrence of ovarian cancer.
    Weiss NS; Lyon JL; Krishnamurthy S; Dietert SE; Liff JM; Daling JR
    J Natl Cancer Inst; 1982 Jan; 68(1):95-8. PubMed ID: 6948131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncontraceptive estrogen use and the risk of breast cancer.
    Kaufman DW; Miller DR; Rosenberg L; Helmrich SP; Stolley P; Schottenfeld D; Shapiro S
    JAMA; 1984 Jul; 252(1):63-7. PubMed ID: 6328053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of postmenopausal hormone use and ovarian cancer risk.
    Danforth KN; Tworoger SS; Hecht JL; Rosner BA; Colditz GA; Hankinson SE
    Br J Cancer; 2007 Jan; 96(1):151-6. PubMed ID: 17179984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
    Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
    Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and epithelial ovarian cancer. Does dose matter?
    Sanderson M; Williams MA; Weiss NS; Hendrix NW; Chauhan SP
    J Reprod Med; 2000 Sep; 45(9):720-6. PubMed ID: 11027080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncontraceptive hormone use and risk of breast cancer.
    Yang CP; Daling JR; Band PR; Gallagher RP; White E; Weiss NS
    Cancer Causes Control; 1992 Sep; 3(5):475-9. PubMed ID: 1525328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen.
    Hildebrand JS; Gapstur SM; Feigelson HS; Teras LR; Thun MJ; Patel AV
    Int J Cancer; 2010 Dec; 127(12):2928-35. PubMed ID: 21351271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis.
    Shi LF; Wu Y; Li CY
    Menopause; 2016 Apr; 23(4):417-24. PubMed ID: 26506499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking and the risk of epithelial ovarian cancer.
    Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
    Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
    Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen replacement therapy and fatal ovarian cancer.
    Rodriguez C; Calle EE; Coates RJ; Miracle-McMahill HL; Thun MJ; Heath CW
    Am J Epidemiol; 1995 May; 141(9):828-35. PubMed ID: 7717359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of breast cancer after estrogen and estrogen-progestin replacement.
    Bergkvist L; Adami HO; Persson I; Hoover R; Schairer C
    N Engl J Med; 1989 Aug; 321(5):293-7. PubMed ID: 2546079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study.
    Palmer JR; Rosenberg L; Clarke EA; Miller DR; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1386-95; discussion 1396-401. PubMed ID: 1663701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncontraceptive estrogens and nonfatal myocardial infarction.
    Jick H; Dinan B; Rothman KJ
    JAMA; 1978 Apr; 239(14):1407-9. PubMed ID: 204804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.